As shown in Table 2, we also found that genetic proxied CD40 levels demonstrate inverse associations with the risk of TAA (OR: 0.906, 95% CI: 0.837–0.981, p = 0.015) and AAA (OR: 0.851, 95% CI: 0.753–0.962, p = 0.010). This evidence concerns the gene CD40 and triple-A syndrome.